ADALIMUMAB (ADA) AND INFLIXIMAB (IFX) THERAPY DURING PREGNANCY IN IBD: A PROSPECTIVE ASSESSMENT OF OUTCOME, SAFETY, ANTI-TNFΑ CORD BLOOD AND FOLLOW UP BLOOD LEVELS IN NEWBORNS

(1) Medical University Vienna



This item was part of the IBD therapy: Safety issues session at UEG Week 2013

This item can be cited as: United European Gastroenterology Journal; 2013: 1 (Supplement 1) A66

You may be interested in:

Screening for hepatocellular carcinoma - in whom and when?
European Society of Digestive Oncology (ESDO), 2014
PREGNANCY OUTCOMES IN PATIENTS WITH CROHN’S DISEASE TREATED WITH INFLIXIMAB: RESULTS FROM THE TREAT™ REGISTRY
English, Medical management, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013

Categorisation:

  • Clinical Specialty
    • 'IBD-ology'
  • Diagnosis and Management
    • Medical management
  • Disease
    • Inflammatory bowel disease
  • Format
    • Abstract
  • Language
    • English
  • Year
    • 2013